Aaron Feldman Email & Phone Number

Israel

Co-founded and lead a company developing and commercializing the only device-based solution for high-risk emergency shoulder dystocia births which place 3M babies and their mothers at risk of debilitating, life-long injury and death. Visit our website: yaariextractor.com.

Zichron Yaacov, Israel

I partner with physician inventors in establishing and incubating new medical device companies in a range of medical domains (cardiovascular, OB/GYN, laparoscopic surgery, others) based on highly innovative, market-focused solutions. To date, I have co-founded and serve as a board director in 3 companies which have secured funding either through partnerships with leading Israeli technology incubators (together with grants from the Israel Innovation Authority) or based on private investment. Restore Medical (Incentive incubator) - www.restoremedical.coArk Surgical (NGT incubator) - www.ark-surgical.comFetalEase (private investment) - www.yaariextractor.comIn Establishment - reach out for investment opportunities:Onco Access Ltd. - Vascular Port Optimized for Today’s Existing and Emerging Oncologic TherapiesAnaconda Vascular - Next Generation Vascular Flow-Diverting Occlusion Coil

Israel

Support of CEOs and companies in a range of company functions particularly business development and strategic marketing. Currently providing support to companies in the field of: surgical robotics, respiratory, AI for improved risk adjustment, GI, orthopedics, and others. Current and previous clients include:Tamar Robotics - founded by Prof. Moshe Shoham (Mazor Robotics), the company is developing the first endoscopic system enabling safe and accurate robotic surgery for neurosurgery (brain tumor removal) and in other small cavities. MST - Medical Surgery Technologies Ltd., an Israeli sales-stage company in the field of image-based analytic technology for the surgical suite. MST was acquired by Transenterix Inc. in November 2018. MotusGI (NASDAQ:MOTS), a company commercializing a device for cleansing the colon during colonoscopy.

CardioFlow Ltd. (a Trendlines Group portfolio company) develops the EmboPRO™, a proximal embolic protection device (EPD) for preventing embolic material such as plaque and clot from obstructing blood flow in arteries.

Rafael Medical developed the SafeFlo(R) Optional Vena Cava Filter for the prevention of pulmonary embolism. The filter received FDA approval as a permanent implant as well as CE Mark for permanent use as well as retrieval.

Business analyst and consultant working with high technology companies as well as with the Israel Ministry of Industry & Trade's Center for Business Promotion.

Mba

Ba, Psychology

Education record